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ABSTRACT 
Almost 80 to 90% of cancer cells show a high telomerase activity compared to 
normal, differentiated cells. Telomerase activity in cancer cells depend on several 
factors: increased hTERT expression, modification of telomerase structural subunits 
and telomere associated proteins. In contrast to other breast cancer types, treatment 
options for Triple Negative Breast Cancer (TNBC) are limited due to a lack of 
specific molecular targets. Therefore, in this study the effect of apigenin, cisplatin and 
the combination of both on telomerase activity and structure was investigated in two 
different types of TNBC (MDA-MB-231 and HCC1806) and one control cell line 
(MCF10A). The transcriptional and translational expression of telomerase subunits 
namely Human telomerase reverse transcriptase (hTERT), Heat Shocked Protein 90 
(Hsp90), Human Prostaglandin E synthase 3 (p23) as well as telomere-associated 
proteins; Telomeric Repeat Binding Factor-1 (TRF1), Telomeric Repeat Binding 
Factor-2 (TRF2), Protection of Telomere 1 (TIN2), TRF1 Interacting Protein 2 
(POT1), POT1 and TIN2- Organizing Protein (TPP1) and Transcriptional 
Repressor/Activator Protein (RAP1) were measured using quantitative Real Time 
Polymerase Chain Reaction (qRT-PCR) and Enzyme-linked Immunosorbent Assay 
(ELISA). Apigenin with cisplatin showed synergistic effects with regards to 
increasing apoptosis and reducing telomerase activity in TNBC cells. However, the 
combined treatment did not show any protective effect on MCF10A cells. Reduction 
of telomerase activity by the combined treatment was associated with the reduction of 
Hsp90 and p23 expression in TNBC cells. The decrease of the shelterin subunits, 
POT1 and TPP1 after combined treatment also seem to be involved in regulating 
telomerase activity in TNBC cells. However, the deactivation of telomerase by the 
combination is strongly dependent on the subtype of TNBC used. In conclusion 
telomerase activity and shelterin components area potential target for the treatment of 
TNBC. However, further studies are required to investigate the effect of combined 
treatment in the non-tumour tissue. To date, this is the first study that demonstrated 
the synergistic effect of apigenin with cisplatin on TNBC cells. 
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